Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:
-
Infinity Natural Resources (INR) — #1 ranked oil & gas stock with unanimous analyst backing
-
Guardian Pharmacy Services (GRDN) — Up 137% since IPO, dominating senior care pharmacy
-
Vertiv Holdings (VRT) — AI data center powerhouse with 2,553% total return
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Buffett's $114 Secret
In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account."
Today, that single, $114 investment would be worth over $15 million.
Your bank never told you about this.
Click Here to See How It Works
1. Infinity Natural Resources Inc (NYSE: INR)
Infinity Natural Resources Inc is on an aggressive growth tear after closing a transformational $1.2 billion acquisition of Ohio Utica Shale assets and an upsized $550 million senior notes offering. With 2025 revenue up 38% year-over-year and a $450–$500 million capital budget for 2026, INR is rapidly becoming one of the most compelling growth stories in oil and gas.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $17.38 — get current quote
Max 1-year forecast: $25.00
Why we're watching:
- Analyst support: INR enjoys unanimous backing with 3 Strong Buy ratings and no Hold or Sell recommendations, reflecting exceptional confidence in the company's trajectory. See the ratings
- Citigroup analyst Paul Diamond (a top 20% rated analyst) maintains a Strong Buy rating with a $25.00 price target, emphasizing the potential for significant market share growth driven by new resource acquisitions.
- KeyBanc's Tim Rezvan (top 23%) sees strong growth potential given current market conditions and strategic positioning, maintaining a $24.00 target representing +38% upside.
- Industry ranking context: INR is currently the #1 highest-rated stock in the Oil and Gas industry, which has an Industry Rating of D, making this standout performer particularly noteworthy.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — INR's leadership position in a challenging sector demonstrates exceptional relative strength and operational excellence.
- Component Grades: The company earns top marks with an A in artificial intelligence integration alongside B grades in Value and Growth, positioning it uniquely among traditional energy plays. See all 7 Zen Component Grades here
2. Guardian Pharmacy Services Inc (NYSE: GRDN)
Guardian Pharmacy Services is one of the nation's leading long-term care pharmacy providers — and Wall Street is taking notice. The stock has surged 98% from its 52-week low and delivered a remarkable 137% total return since its September 2024 IPO, fueled by explosive momentum and a recently completed upsized public offering to accelerate its expansion in the booming senior care market.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $37.99 — get current quote
Max 1-year forecast: $44.00
Why we're watching:
- Analyst support: GRDN commands strong Wall Street backing with 3 Strong Buy ratings and 1 Buy rating out of 4 total analysts, demonstrating broad confidence despite the company's recent IPO in September 2024. See the ratings
- Jefferies analyst Brian Tanquilut (a top 16% rated analyst) recently initiated coverage with a Strong Buy rating and $44.00 price target following the company's Q4 2025 earnings, citing innovative operational strategies and strong market positioning.
- Truist Securities' David S Macdonald (top 11%) and Stephens & Co.'s Scott Fidel (top 13%) both maintain Strong Buy ratings, highlighting the company's superior execution in a fragmented market.
- Industry ranking context: GRDN is currently the 6th highest-rated stock in the Medical Care Facility industry, which has an Industry Rating of A, placing it among elite healthcare service providers.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — GRDN has already delivered a remarkable 137% total return since its September 2024 listing at $16.00.
- Component Grades: The company excels with an A in Financials and Sentiment alongside B grades in Growth and Momentum, reflecting strong operational execution and positive market reception. See all 7 Zen Component Grades here
3. Vertiv Holdings (NYSE: VRT)
Vertiv Holdings is powering the AI revolution. The company provides mission-critical infrastructure for data centers worldwide, and with AI-driven demand accelerating and liquid cooling technologies emerging as the next supercycle, Vertiv is trading near its 52-week high as one of the most essential enablers of the global data center buildout.
Zen Rating: B (Buy) — see full analysis
Recent Price: $261.29 — get current quote
Max 1-year forecast: $325.00
Why we're watching:
- Analyst support: VRT enjoys robust Wall Street backing with 9 Strong Buy ratings, 4 Buy ratings, and just 1 Hold out of 14 total analysts, reflecting widespread confidence in the AI infrastructure thesis. See the ratings
- Barclays' Julian Mitchell (a top 1% rated analyst) maintains a Strong Buy rating with a $300.00 price target, while HSBC researcher Wesley Brooks recently initiated coverage with a Strong Buy and $325.00 target representing +24% upside potential.
- Citigroup's Andy Kaplowitz (top 1%) and Goldman Sachs' Mark Delaney (top 2%) both maintain Strong Buy ratings with $286.00 and $277.00 targets respectively, citing accelerating data center demand.
- Industry ranking context: VRT is currently the 4th highest-rated stock in the Electrical Equipment & Parts industry, which has an Industry Rating of D, making its exceptional performance stand out sharply against sector peers.
- Zen Rating highlights: Buy (B) stocks average +19.88%/yr — VRT has delivered an extraordinary 2,553% total return since its July 2018 listing at $9.85, representing 59.73% annualized gains.
- Component Grades: The company earns an A in Financials with B grades in Growth, Momentum, and Sentiment, reflecting strong execution in the high-growth AI infrastructure market. See all 7 Zen Component Grades here
What to Do Next?